Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RandOmised Arthroplasty Infection worlDwide Multidomain Adaptive Platform (ROADMAP) Trial

NCT06771050 is registered in ClinicalTrials.gov with University of Newcastle, Australia as lead sponsor.

NCT NCT06771050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06771050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RandOmised Arthroplasty Infection worlDwide Multidomain Adaptive Platform (ROADMAP) Trial
Lead sponsor
University of Newcastle, Australia
Phase
Phase 4
Overall status
Recruiting
Start date
March 24, 2025
Completion date
December 31, 2029
Enrollment
2,500 (estimated)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

large joint prosthetic joint infections, prosthetic joint infections of hip, prosthetic joint infections of knee